Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2003
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/10/2003EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors
12/10/2003EP1369409A1 Process for preparing compounds useful as intermediates
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368316A1 Oxoammonium salts and the use thereof
12/10/2003EP1368315A1 Method for preparing amlodipine
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368313A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1130403C In situ block copolymer formation during polymerization of vinyl axomatic monomer
12/09/2003US6660885 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
12/09/2003US6660739 Heterocyclic amides as inhibitors of factor Xa
12/09/2003US6660181 Inhibition of polymerization of unsaturated monomers
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099790A1 Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
12/04/2003WO2003099788A1 Piperidine derivatives
12/04/2003WO2003099787A1 Novel piperidine compound
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003045917B1 Ccr-3 receptor antagonists vii
12/04/2003WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle
12/04/2003WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure
12/04/2003WO2002086138A3 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
12/04/2003WO2002065977A3 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225143 A nicotinate salt of amlodipine, used as hypotensive agents, antiischemic agents; stability, water solubility
12/04/2003US20030225133 N-and o-substituted 4-[2-( diphenylmethoxy) -ethyl]-1- (phenyl) methyl) piperidine analogs and methods of treating cns disorders therewith
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/04/2003US20030225120 Dihydropyridine soft drugs, and related compositions and methods
12/04/2003US20030225116 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine
12/04/2003US20030225108 Process for making substituted pyrazoles
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003US20030225060 Acylated piperidine derivatives as melanocortin-4 receptor agonists
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030224348 Methods of screening for SCAP antagonists
12/04/2003US20030224347 Pharmaceutical compositions
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/03/2003EP1366030A2 Melanin concentrating hormone receptor ligands
12/03/2003EP1366018A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129580C Method for crystallisation of tetrahydropyridin derive and resulting crystalline forms
12/03/2003CN1129579C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
12/02/2003US6657062 Chemical intermediates for paroxetine derivatives; formylation, resolution, reduction, salt formation, catalysis
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656953 4,4-Disubstituted piperidines, and methods of use thereof
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656694 Detection of preferential particles in sample; obtain sample containing particle, incubate with modulators, monitor binding activity of particles
11/2003
11/27/2003WO2003097855A2 Small molecule inhibitors of her2 expression
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097600A1 Method for producing cyclic imides in the presence of polyphosphoric acid
11/27/2003WO2003097599A1 Preparation of 4-(4-fluorophenyl)-n-substitutednipecotinate esters
11/27/2003WO2003097589A1 Method for the production of sulphamic acid halogenides
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003096991A2 Amelioration of the development of cataracts and other opthalmic diseases
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003096987A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2002074735A3 Biurethane derivatives
11/27/2003US20030220501 A chemical intermediates for making phthalimidoamlodipine, and further deprotecting to form amlodipine calcium channel blockers
11/27/2003US20030220496 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220423 A polymerization catalyst for free radical polymerization of ethylenically unsaturated monomers
11/27/2003US20030220400 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
11/27/2003US20030220370 Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-aralkylnipecotinate esters
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors
11/27/2003US20030220299 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030220196 Phenyl-substituted-2enamino-keto nitriles
11/27/2003CA2486148A1 Process for the preparation of cyclic imides in the presence of polyphosphoric acid
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2485589A1 Small molecule inhibitors of her2 expression
11/27/2003CA2485586A1 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003CA2485360A1 Method for the production of sulphamic acid halogenides
11/27/2003CA2484512A1 Treatment of cataracts and other ophthalmic diseases
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363883A1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith
11/26/2003EP1363882A1 3-(3-amidinophenyl)-5- ( 1-(1-(-iminoethyl)-4-piperidyl amino)methyl]benzoic acid dihydrochloride and process for preparing the same
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363630A2 Kappa opioid receptor ligands
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 380